Open access
Open access
Powered by Google Translator Translator

Pediatrics – Hematology/Oncology

ASCO Guideline | Management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients

24 Jan, 2023 | 14:28h | UTC

Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update – Journal of Clinical Oncology

 


NCCN Guideline | Pediatric central nervous system cancers

12 Jan, 2023 | 13:11h | UTC

Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Editorial: ASCO Living Guidelines: The Next Frontier

 


Review | Palliative care for adolescents and young adults with advanced illness.

12 Dec, 2022 | 12:33h | UTC

Palliative care for adolescents and young adults with advanced illness: A scoping review – Palliative Medicine

 


Joint consensus statement on the vaccination of adult and pediatric hematopoietic stem cell transplant recipients.

30 Nov, 2022 | 13:39h | UTC

Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children’s cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) – Journal of Infection

 


Guideline | Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients.

8 Nov, 2022 | 12:21h | UTC

Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A Clinical practice guideline – Pediatric Blood & Cancer (PDF)

 


RCT | Brentuximab Vedotin with chemotherapy in pediatric high-risk Hodgkin’s Lymphoma.

4 Nov, 2022 | 13:30h | UTC

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, trial shows – News Medical

 


2022 ETA Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.

27 Oct, 2022 | 12:33h | UTC

2022 ETA Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma – European Thyroid Journal

Commentary: New EU Guidelines: Individualize Care for Thyroid Cancer in Kids – Medscape (free registration required)

 


Systematic Review | Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.

21 Oct, 2022 | 12:47h | UTC

Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines – Cochrane Library

Summary: Can the medicine dexrazoxane prevent or reduce heart damage in adults and children with cancer receiving anthracyclines? – Cochrane Library

 


Guideline | Diagnosis and management of febrile neutropenia in patients with cancer.

18 Oct, 2022 | 12:52h | UTC

The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer – Infectious Diseases and Therapy

Related:

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update – Journal of Clinical Oncology

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO) – Annals of Hematology

SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018) – Clinical and Translational Oncology

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update

 


Consensus recommendations for screening and managing childhood cancer survivors at risk for cardiomyopathy.

11 Oct, 2022 | 13:35h | UTC

Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy – JACC: CardioOncology

Related:

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors – Journal of Clinical Oncology

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) – European Heart Journal – Cardiovascular Imaging

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations – Annals of Oncology

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement from the American Heart Association – Circulation

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases – European Heart Journal. Acute Cardiovascular Care

Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia

AHA Statement: Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors

 


Retrospective cohort | Outcomes in relapsed neuroblastoma treated with Irinotecan / Temozolomide / Dinutuximab / GM-CSF.

11 Oct, 2022 | 13:30h | UTC

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor – Journal of Clinical Oncology

 


RCT | Effect of the family-centered advance care planning for teens with cancer intervention on sustainability of congruence about end-of-life treatment preferences.

22 Sep, 2022 | 13:02h | UTC

Effect of the Family-Centered Advance Care Planning for Teens with Cancer Intervention on Sustainability of Congruence About End-of-Life Treatment Preferences: A Randomized Clinical Trial – JAMA Network Open

News Release: Advance care planning for adolescents with cancer – University of Minnesota

Commentary: Study Examines Effects of Advance Care Planning for Adolescents With Cancer – The ASCO Post

 

Commentary on Twitter

 


Large study unravels the risk factors for heart failure among childhood cancer survivors.

11 Sep, 2022 | 22:22h | UTC

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors – Journal of Clinical Oncology

 


Cohort Study | Children conceived via assisted reproductive technologies are at increased risk of childhood cancers.

7 Sep, 2022 | 12:32h | UTC

Assisted Reproductive Technology and Risk of Childhood Cancers – JAMA Network Open

Invited Commentary: Fertility Treatment and Childhood Cancer Risk – JAMA Network Open

 

Commentary on Twitter

 


Systematic Review | Adverse drug reactions in pediatric onco-hematology

2 Sep, 2022 | 13:05h | UTC

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review – Frontiers in Pharmacology

 


Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.

2 Sep, 2022 | 13:02h | UTC

Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management – International Journal of Dermatology

 


Measuring quality of dying, death and end-of-life care for children and young people: a scoping review of available tools.

26 Aug, 2022 | 13:14h | UTC

Measuring quality of dying, death and end-of-life care for children and young people: A scoping review of available tools – Palliative Medicine

 


M-A | Extent of tumor resection and survival in pediatric patients with high-grade gliomas.

17 Aug, 2022 | 14:00h | UTC

Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis – JAMA Network Open

 

Commentary on Twitter

 


Guideline | Pediatric differentiated thyroid carcinoma.

29 Jul, 2022 | 12:31h | UTC

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline – Endocrine-Related Cancer

 


Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children.

8 Jul, 2022 | 11:20h | UTC

Evaluation of the Molecular Landscape of Pediatric Thyroid Nodules and Use of a Multigene Genomic Classifier in Children – JAMA Oncology

 

Commentaries on Twitter

 


Phase 1 single-arm study | Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma.

4 Jul, 2022 | 12:08h | UTC

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Oncolytic Virus Infusion Promising as Brain-Stem Glioma Treatment — Phase I trial shows encouraging OS in children with diffuse intrinsic pontine glioma – MedPage Today (free registration required)


10-year outcomes of a RCT: Time to cure for childhood and young adult Acute Lymphoblastic Leukemia is independent of early risk factors.

20 Jun, 2022 | 00:49h | UTC

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


RCT: Efficacy of mobile instant messaging–delivered brief motivational interviewing for parents to promote physical activity in pediatric cancer survivors.

15 Jun, 2022 | 10:53h | UTC

Efficacy of Mobile Instant Messaging–Delivered Brief Motivational Interviewing for Parents to Promote Physical Activity in Pediatric Cancer Survivors: A Randomized Clinical Trial – JAMA Network Open

Invited commentary: Improving Physical Activity in Pediatric Cancer Survivors—Engaging Parents – JAMA Network Open

 

Commentary on Twitter

 


Cross Sectional Study: Underdiagnosis and undertreatment of modifiable cardiovascular risk factors among survivors of childhood cancer.

15 Jun, 2022 | 10:43h | UTC

Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer – Journal of the American Heart Association

Commentaries:

Survivors of Childhood Cancer More Likely to Be Undertreated for CVD Risk Factors – AMJC

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors – News Medical

 


ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children.

7 Jun, 2022 | 10:52h | UTC

ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children – Radiotherapy & Oncology

 


Stay Updated in Your Specialty

No spam, just news.